62 Recruiting Pancreatic Adenocarcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Pancreatic Adenocarcinoma Studies
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
View Study & Checklist ➔Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
📍 Juravinski Hospital — Hamilton, Ontario
View Study & Checklist ➔A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma
📍 Baylor College of Medicine Medical Center - McNair Campus — Houston, Texas
View Study & Checklist ➔Hypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic Cancer
📍 University of Nebraska Medical Center — Omaha, Nebraska
View Study & Checklist ➔FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
📍 University of Colorado Cancer Center — Aurora, Colorado
View Study & Checklist ➔9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
📍 University of Rochester — Rochester, New York
View Study & Checklist ➔Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
📍 Stanford University, School of Medicine — Palo Alto, California
View Study & Checklist ➔Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
View Study & Checklist ➔Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
📍 Baylor University Medical Center, Charles A Sammons Cancer Center — Dallas, Texas
View Study & Checklist ➔Prospective Validation of an EHR-based Pancreatic Cancer Risk Model
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Lorigerlimab (MGD019) in Patients With Pancreatic Adenocarcinoma and Homologous Recombination Deficiency
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
📍 Corewell Health West — Grand Rapids, Michigan
View Study & Checklist ➔Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
📍 University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
View Study & Checklist ➔Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
📍 University of Louisville — Louisville, Kentucky
View Study & Checklist ➔Multicenter Trial of ESK981 in Patients With Select Solid Tumors
📍 Rogel Cancer Center — Ann Arbor, Michigan
View Study & Checklist ➔Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔